共 50 条
- [32] SERUM SOLUBLE IL-2 RECEPTOR LEVELS CORRELATE WITH CLINICAL TYPE AND DISEASE-ACTIVITY IN JUVENILE RHEUMATOID-ARTHRITIS CLINICAL RESEARCH, 1990, 38 (02): : A580 - A580
- [34] Modulation of hu/mu severe combined immunodeficient (SCID) mouse arthritis by local application of human recombinant IL-1 beta, IL-2 and IL-6 CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 107 (01): : 96 - 102
- [35] SWITCH FROM A TYPE-1 LYMPHOKINE RESPONSE (IL-2) TO A TYPE-2 RESPONSE (IL-10) IN PATIENTS WITH CHRONIC RHEUMATOID-ARTHRITIS FASEB JOURNAL, 1995, 9 (04): : A822 - A822
- [36] CORRELATIONS BETWEEN IL-2 ENHANCING ACTIVITY AND CLINICAL-PARAMETERS IN PATIENTS WITH RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 163 (04): : 269 - 277
- [38] DIMINISHED IL-2-INDUCED GAMMA-INTERFERON PRODUCTION BY UNSTIMULATED PERIPHERAL-BLOOD LYMPHOCYTES IN RHEUMATOID-ARTHRITIS BRITISH JOURNAL OF RHEUMATOLOGY, 1988, 27 (01): : 15 - 20
- [39] SUPPRESSION OF IN-VITRO IGM AND IGM RHEUMATOID-FACTOR PRODUCTION BY DAB486IL-2 FUSION TOXIN THERAPY IN RHEUMATOID-ARTHRITIS (RA) ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S130 - S130
- [40] TREATMENT OF REFRACTORY RHEUMATOID-ARTHRITIS WITH DAB(486)IL-2 FUSION TOXIN - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R24 - R24